期刊文献+

高效液相色谱-质谱联用测定小鼠血浆中FG-4592浓度及其药动学研究 被引量:4

Determination of FG-4592 in mice plasma and pharmacokinetic study by LC-MS/MS method
下载PDF
导出
摘要 目的建立LC-MS/MS法检测小鼠血浆内FG-4592的浓度,研究FG-4592在小鼠体内的药代动力学。方法KM小鼠腹腔注射FG-4592 5 mg/kg,不同时间点采集血浆,样品经甲醇沉淀。选用Agilent Zorbax SB-Aq-C18色谱柱(2.1 mm×100 mm,3.5μm),柱温25℃,流动相为甲醇-水(含5 mmol/L甲酸铵,0.1%甲酸)(90∶10),流速0.35 m L/min。采用ESI离子源,正离子模式多反应监测,离子通道分别为m/z 353.1→m/z 278.1(FG-4592)和m/z294.9→m/z 235.0(内标物)。结果测定血浆中FG-4592的线性范围为1~1000 ng/m L,日内及日间精密度均〈10%,准确度在90%~105%范围内,方法学考察均符合生物样品的分析要求。药代动力学参数:Cmax为(22.80±0.36)μg/m L,AUC(0-72)为(31.64±0.97)(μg·h)/m L,t1/2为8.81 h。结论本研究建立的FG-4592血药浓度测定方法可行,该药物在血液中吸收良好,测定结果可为药物的基础研究提供依据。 Objective To develop a LC-MS/MS method for the quantitative analysis of FG-4592 in mice plasma and to study the pharmacokinetic profile of FG-4592 with this method. Methods KM mice were intraperitoneally administered5 mg/kg FG-4592. The plasma samples were collected at different time points and precipitated by methanol. An Agilent Zorbax C18(2.1 mm×100 mm, 3.5 μm) chromatographic column with the column temperature of 25℃ was used.The mobile phase consisted of methanol-water(contained 5 mmol/L ammonium formate and 0.1 % formic acid)(90∶10).The flow rate of mobile phase was 0.35 m L/min. The analyte was monitored by positive electrospray ionization(ESI) in multiple reaction monitoring mode. The mass transition pairs was m/z 353.1→ m/z 278.1(FG-4592) and m/z 294.9→m/z 235.0(internal standard) respectively. Results The calibration curve was established in concentration range of 1-1000 ng/m L. The intra-and inter-day RSDs were both less than 10%. The method recoveries were within 90%-105%and met for the requirements of biological sample analysis. The pharmacokinetic parameters were as follows: Cmaxwas(22.80±0.36) μg/m L, AUC(0-72)was(31.64±0.97)(μg·h)/m L, t1/2was 8.81 h. Conclusion This method is reliable. FG-4592 is well absorbed in mice blood and the results can provide the basis for fundamental research.
出处 《中国医药导报》 CAS 2016年第9期14-17,42,共5页 China Medical Herald
基金 国家自然科学基金资助项目(81273519) 上海交通大学医工交叉基金资助项目(YG2015MS07)
关键词 FG-4592 高效液相色谱-质谱联用 药代动力学 FG-4592 LC-MS/MS Pharmacokinetic
  • 相关文献

参考文献25

  • 1Besarab A, Chernyavskaya E, Motylev I, et al. Roxadustat (FG -4592) :correction of anemia in incident dialysis patients [J]. Journal of the American Society of Nephrology, 2015 : ASN.2015030241.
  • 2Flight MH. Deal watch:AstraZeneca bets on FibroGen's anaemia drug [J]. Nature Reviews Drug Discovery,2013,12 (10) :730.
  • 3Bouchie A. First-in-class anemia drug takes aim at Amgen's dominion [J]. Nature biotechnology, 2013,31 (11) : 948-949.
  • 4Bruick RK, McKnight SL. A conserved family of prolyl-4- hydroxylases that modify HIF [J]. Science,2001,294(5545) : 1337-1340.
  • 5Smith TG,Talbot NP. Prolyl hydroxylases and therapeutics [J]. Antioxidants & redox signaling, 2010,12 (4) : 431-433.
  • 6Myllyharju J. HIF prolyl 4-hydroxylases and their potential as drug targets [J]. Current pharmaceutical design, 2009,15 (33) : 3878-3885.
  • 7Metzen E,Ratcliffe PJ. HIF hydroxylation and cellular oxygen sensing [J]. Biological chemistry, 2004,385(3-4) : 223-230.
  • 8Adamcio B,Sperling S,Hagemeyer N,et al. Hypoxia inducible factor stabilization leads to lasting improvement of hipp- ocampal memory in healthy mice [J]. Behavioural brain research, 201 O, 208 ( 1 ) : 80-84.
  • 9Reischl S, Li L, Walkinshaw G,et al Inhibition of HIF pro]yl- 4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during isehemic stroke [J]. PLoS One, 2014 Jan 7;9(t) :e84767.
  • 10Jones SM,Novak AE,Elliott JP. The role of HIF in cobalt- induced ischemic tolerance [J]. Neuroscience,2013,252: 420-430.

二级参考文献205

共引文献142

同被引文献32

引证文献4

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部